We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read more about cookies

+46 (0) 8 - 588 660 00
  • Register
  • Log in
  • Language
Show submenu Hide submenu

A global leader in a global market

Sweden is Northern Europe’s largest and most dynamic life science regions with world class companies, internationally acclaimed science and a proud track record of investments in the innovations of tomorrow. The country offers exciting business opportunities in an environment dedicated to medical innovation, drug discovery and pharmaceutical commercialisation.

Sweden’s success rests on an unswerving commitment to excellence in R&D and drug discovery. Per capita spending on life science is one of the highest in Europe. Swedish universities possess world class expertise in areas ranging from cancer and diabetes research to medical devices and stem cell therapies. Sweden is renowned for high quality clinical trials, biobanks and registers including the world’s largest twin register. Also, studies of how genetic and environmental factors affect health can probably be conducted more accurately than anywhere else thanks to an extensive network of national databanks.

A unique model of close collaboration between industry, academia and clinical practitioners has fostered the growth of world leading pharmaceutical companies like Astra, now a part of AstraZeneca, and Pharmacia, now a part of Pfizer.

The Swedish life science sector has great potential for investors and partners across multiple areas. Numerous projects are going on at a regional level, such as:

  • The New Karolinska Solna University Hospital - strengthening Stockholm’s position as a world leading life science cluster
  • The European Spallation Source (ESS) in Lund in southern Sweden – a European research facility for materials research under construction
  • Gothenburg - striving for international leadership in regenerative medicine
  • Umeå  - a global research leader in infectious disease treatment and sports medicine

Why Sweden?

In addition to the above regional projects:

  • Proven track record of success in innovation
  • Access to knowledge capital through biobanks and registers, for example one of the best and largest biobanks in diabetes research worldwide
  • World leader in biomaterials and orthopedic implants, transplantation, regenerative medicine, gene therapy, medical implants, drug development, genomics and proteomics, diagnostics and renal care
  • World leading research in multiple therapeutic areas: oncology, neuroscience, inflammation and metabolics
  • Interdisciplinary approach to biomedical research and development
  • Expertise and infrastructure in the area of imaging and visualisation 

More information about the Life Science sector in Sweden.

Carl Morath

Senior Investment Advisor, Life Sciences Stockholm, Sweden Senior Investment Advisor, Life Sciences , Stockholm, Sweden
+46 73 038 77 23
E-mail carl.morath@business-sweden.se

Markus Thor

Investment Advisor Stockholm, Sweden Investment Advisor, Stockholm, Sweden
+46 70 232 24 16
E-mail markus.thor@business-sweden.se

Do you want us to contact you?